Similar articles for PMID: 20135056

Year	Number of Results
1990	1
1991	1
1995	2
1996	1
1999	1
2000	8
2001	8
2002	4
2003	7
2004	6
2005	8
2006	9
2007	8
2008	13
2009	18
2010	20
2011	28
2012	24
2013	30
2014	26
2015	21
2016	13
2017	9
2018	9
2019	9
2020	4
2021	2
2023	1
2024	0

1

Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.

Lip GY. Lip GY. Thromb Haemost. 2010 Apr;103(4):683-5. doi: 10.1160/TH10-01-0038. Epub 2010 Feb 2. Thromb Haemost. 2010. PMID: 20135056 No abstract available.

2

Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.

Gorin L, Fauchier L, Nonin E, de Labriolle A, Haguenoer K, Cosnay P, Babuty D, Charbonnier B. Gorin L, et al. Thromb Haemost. 2010 Apr;103(4):833-40. doi: 10.1160/TH09-10-0746. Epub 2010 Feb 2. Thromb Haemost. 2010. PMID: 20135077

3

Atrial fibrillation and anticoagulation.

Maxim R. Maxim R. Med Health R I. 2001 Mar;84(3):96-7. Med Health R I. 2001. PMID: 11280139 No abstract available.

4

'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.

Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP. Lip GY, et al. Am J Med. 2014 Jun;127(6):519-29.e1. doi: 10.1016/j.amjmed.2013.12.022. Epub 2014 Jan 28. Am J Med. 2014. PMID: 24486284 Free article.

5

Stroke prevention in atrial fibrillation patients.

Marinigh R, Lip GY, Lane DA. Marinigh R, et al. Expert Opin Pharmacother. 2010 Oct;11(14):2331-50. doi: 10.1517/14656566.2010.498819. Expert Opin Pharmacother. 2010. PMID: 20718589 Review.

6

[Anticoagulation therapy in paroxysmal atrial fibrillation].

Risøe C, Gjesdal K. Risøe C, et al. Tidsskr Nor Laegeforen. 2004 Apr 1;124(7):950-2. Tidsskr Nor Laegeforen. 2004. PMID: 15060644 Free article. Review. Norwegian.

7

[What anticoagulant therapy should be used for what form of atrial fibrillation?].

Frantz E. Frantz E. Dtsch Med Wochenschr. 2000 Apr 20;125 Suppl 1:S10-1. Dtsch Med Wochenschr. 2000. PMID: 10818997 German. No abstract available.

8

[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].

Själander A, Wallentin L, Rosenqvist M, Svensson P. Själander A, et al. Lakartidningen. 2008 Sep 10-16;105(37):2478-80. Lakartidningen. 2008. PMID: 19006862 Swedish. No abstract available.

9

Cardioembolic stroke: call for a multidisciplinary approach.

Babarro EG, Rego AR, González-Juanatey JR. Babarro EG, et al. Cerebrovasc Dis. 2009;27 Suppl 1:82-7. doi: 10.1159/000200444. Epub 2009 Apr 3. Cerebrovasc Dis. 2009. PMID: 19342836 Review.

10

Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.

Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ; ACTIVE W Investigators. Hohnloser SH, et al. J Am Coll Cardiol. 2007 Nov 27;50(22):2156-61. doi: 10.1016/j.jacc.2007.07.076. Epub 2007 Nov 13. J Am Coll Cardiol. 2007. PMID: 18036454 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

267 results

Results by year